BIOMAT Database Logo BIOMAT Database Logo

Systolic ventricular dysfunction causes selective diaphragm atrophy in rats. 1998

G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
Respiratory Muscle Research Unit, Laboratory for Pneumology and Respiratory Division, University Hospitals, Katholieke Universiteit Leuven, Belgium.

In order to examine the relative impairment of the diaphragm and other skeletal muscles in systolic ventricular dysfunction (VD), their structure and function were compared between rats with VD induced by left coronary artery ligation (n = 17) and sham-operated rats (Co, n = 10). In addition, in an attempt to unravel the mechanism of the observed impairment, we examined alterations in insulin-like growth factor-I (IGF-I) serum levels and IGF-I expression in the liver, diaphragm, and gastrocnemius. In a second series of rats (VD, n = 5 and Co, n = 5) hemodynamic measurements were performed. All measurements were performed 3 mo after the operation. Infarct size averaged 32 +/- 10 and 44 +/- 20% in the two series, respectively (NS). Hemodynamic measurements revealed a decrease in left ventricular peak systolic pressure of 19% (p < 0. 05). Significant diaphragm atrophy (weight: 622 +/- 52 mg in VD versus 750 +/- 54 mg in Co, p < 0.0005), without alterations in diaphragm contractile properties was present in VD animals. For all animals combined, the reduction in diaphragm weight was related to infarct size (r = -0.74, p < 0.001). No alterations were observed in the other inspiratory and peripheral muscles. ATPase staining of the diaphragm showed atrophy of type I and type IIx/b fibers, their cross-sectional area (CSA) being reduced by 13 and 16%, respectively (p < 0.05). There were no signs of myopathic alterations. IGF-I expression was increased by 55% in the diaphragm of rats with VD (p < 0.05). IGF-I expression in the liver and gastrocnemius and serum IGF-I levels were unaltered. These data suggest the presence of compensatory mechanisms aimed at minimizing diaphragmatic fiber atrophy. We conclude that systolic VD caused: (1) selective diaphragm atrophy, which was related to infarct size; (2) a decrease in diaphragm type I and IIx/b CSA not associated with myopathic changes; (3) an increase in the IGF-I mRNA content of the diaphragm. The selective diaphragm involvement in the present study may be related to the moderate degree of ventricular dysfunction induced.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D012132 Respiratory Muscles These include the muscles of the DIAPHRAGM and the INTERCOSTAL MUSCLES. Ventilatory Muscles,Respiratory Muscle,Muscle, Respiratory,Muscle, Ventilatory,Muscles, Respiratory,Muscles, Ventilatory,Ventilatory Muscle
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D003964 Diaphragm The musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION. Respiratory Diaphragm,Diaphragm, Respiratory,Diaphragms,Diaphragms, Respiratory,Respiratory Diaphragms
D004396 Coloring Agents Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. Coloring Agent,Dye,Dyes,Organic Pigment,Stain,Stains,Tissue Stain,Tissue Stains,Organic Pigments,Pigments, Inorganic,Agent, Coloring,Inorganic Pigments,Pigment, Organic,Pigments, Organic,Stain, Tissue,Stains, Tissue

Related Publications

G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
Spinal Cord Injury Causes Systolic Dysfunction and Cardiomyocyte Atrophy.
February 2018, Journal of neurotrauma,
G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
Peritonitis causes diaphragm weakness in rats.
April 1998, American journal of respiratory and critical care medicine,
G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
[Left ventricular systolic dysfunction in cardiomyopathies].
July 1996, Archives des maladies du coeur et des vaisseaux,
G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
[Asymptomatic left ventricular systolic dysfunction].
January 1997, Duodecim; laaketieteellinen aikakauskirja,
G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
Mechanical ventilation causes diaphragm dysfunction in newborn lambs.
April 2019, Critical care (London, England),
G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
Diaphragm atrophy and weakness in cortisone-treated rats.
December 1989, Journal of applied physiology (Bethesda, Md. : 1985),
G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
Isolated right ventricular systolic dysfunction in scleroderma.
September 2008, Revista espanola de cardiologia,
G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
Rethinking Revascularization in Left Ventricular Systolic Dysfunction.
January 2017, Circulation. Heart failure,
G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
Treatment order in managing systolic ventricular dysfunction.
July 2005, Journal of the American College of Cardiology,
G Stassijns, and G Gayan-Ramirez, and P De Leyn, and G Verhoeven, and P Herijgers, and V de Bock, and R Dom, and R Lysens, and M Decramer
Left ventricular systolic dysfunction in rheumatoid disease.
October 2006, Journal of the American College of Cardiology,
Copied contents to your clipboard!